Ryvu Therapeutics S.A. (WSE:RVU)
Poland · Delayed Price · Currency is PLN 15.38
-0.02 (-0.13%)
Jun 12, 2026, 5:00 PM CET
Ryvu Therapeutics Cash Flow Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -88.6 | -101.23 | -111.44 | -92.11 | -83.78 | -79.08 |
Depreciation & Amortization | 9.58 | 9.86 | 10.5 | 10.97 | 12.9 | 12.56 |
Loss (Gain) From Sale of Investments | 0.22 | 10.4 | 0.13 | 3.57 | 8.93 | -0.29 |
Stock-Based Compensation | -0.86 | - | - | - | - | - |
Other Operating Activities | 14.36 | 8.71 | -8.09 | 7.29 | 17.04 | 22.74 |
Change in Accounts Receivable | 8.15 | 15.68 | -2.94 | -15.91 | -5.56 | -3.79 |
Change in Inventory | -0.13 | -0.13 | 0.91 | -0.36 | 0.2 | -0.28 |
Change in Unearned Revenue | -4.54 | -0.95 | -6.89 | 5.09 | 70.43 | -13.91 |
Change in Other Net Operating Assets | -30.94 | -56.44 | -11.67 | -3.09 | 1.61 | 8.77 |
Operating Cash Flow | -92.76 | -114.1 | -129.48 | -84.55 | 21.32 | -58.89 |
Capital Expenditures | -7.41 | -7.47 | -5.9 | -8.58 | -6.25 | -11.98 |
Investment in Securities | -20.53 | - | - | -192.61 | 4.47 | 19.98 |
Other Investing Activities | 23.44 | 24.64 | 143.07 | 5.65 | 2.48 | 0.06 |
Investing Cash Flow | -4.5 | 17.16 | 137.17 | -195.54 | 0.69 | 8.06 |
Long-Term Debt Issued | - | - | 94.66 | 0.13 | 1.15 | 1.02 |
Long-Term Debt Repaid | - | -3.05 | -0.44 | -1.79 | -2.51 | -3.21 |
Net Debt Issued (Repaid) | -2.93 | -3.05 | 94.22 | -1.66 | -1.37 | -2.19 |
Issuance of Common Stock | - | - | - | 250.28 | - | 0.24 |
Other Financing Activities | 0 | 0 | -0.01 | -7.79 | -1.09 | -0.2 |
Financing Cash Flow | -2.93 | -3.05 | 94.21 | 240.83 | -2.46 | -2.15 |
Foreign Exchange Rate Adjustments | -1.87 | -0.48 | 0.24 | -4.72 | -0.87 | - |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | 0 |
Net Cash Flow | -102.06 | -100.47 | 102.13 | -43.98 | 18.68 | -52.98 |
Free Cash Flow | -100.17 | -121.57 | -135.38 | -93.13 | 15.07 | -70.87 |
Free Cash Flow Margin | -113.34% | -138.62% | -132.78% | -138.39% | 22.01% | -200.12% |
Free Cash Flow Per Share | -4.33 | -5.26 | -5.86 | -4.07 | 0.82 | -3.86 |
Cash Interest Paid | - | - | 0.01 | 0.1 | 1.09 | 0.2 |
Cash Income Tax Paid | - | - | - | - | 5.46 | - |
Levered Free Cash Flow | -65.73 | -82.5 | -59.48 | 196.8 | -255.29 | -28.13 |
Unlevered Free Cash Flow | -58.93 | -77 | -57.1 | 196.86 | -254.61 | -27.85 |
Change in Working Capital | -27.47 | -41.83 | -20.58 | -14.28 | 66.23 | -14.82 |